Your browser is no longer supported. Please, upgrade your browser.
NEW! We've added Bitcoin charts to our Forex section. ×
Health Care Select Sector SPDR ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-0.64%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-0.23%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter2.77%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y9.86%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year27.52%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range58.00 - 76.01 Perf YTD8.84%
Dividend0.97 P/FCF- EPS past 5Y- ROI- 52W High-2.35% Beta-
Dividend %1.31% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low27.96% ATR0.78
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)54.11 Volatility0.75% 1.08%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.05 Prev Close74.98
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume9.20M Price74.22
Recom- SMA201.01% SMA501.05% SMA2008.33% Volume9,146,100 Change-1.01%
May-23-15 08:19AM  What You Need To Know About This Higher Risk Stage Of The Bull Market
May-22-15 01:56PM  3 Smart summer trades
12:06PM  What Is the Expected Timing of the PallDanaher Transaction?
12:06PM  Danaher Intends to Split Up Next Year
07:00AM  Scouring S&P 500 Sectors For Bargains at Morningstar
May-21-15 03:57PM  Pall-Danaher Transaction: What You Should Know about Danaher
03:57PM  Pall-Danaher Transaction: An Overview of Pall
11:42AM  Basics of the PallDanaher Transaction
11:41AM  The PallDanaher Spread is Trading Like a Safe Deal
May-19-15 11:21AM  Will Healthcare and Biotech Propel Stocks Higher? at Forbes
May-15-15 10:16AM  Solid Jobs Growth Points to US Economic Health
09:23AM  These 4 ETFs Are Outpacing the Broader Stock Market at TheStreet
08:04AM  UHS CEO: Information, transforming health care
May-14-15 04:02PM  HospiraPfizer Deal Update: Shareholder Approval, 2nd Request
11:06AM  Should You Set Up the Synageva BioPharmaAlexion Spread?
10:06AM  Times Like These Call for Factor Funds
08:52AM  Adding a Factor Fund Gives You Tactical Exposure
May-13-15 03:07PM  Alexion Pharmaceuticals: A Focus on Treating Rare Disorders
03:07PM  Synageva BioPharma: A Pipeline of Therapeutic Programs
06:44AM  Your prescriptions costs what?
May-12-15 04:25PM  The SynagevaAlexion Merger: Stock and Cash Considerations
04:25PM  Alexion Pharmaceuticals Pays up to Get Synageva BioPharma
11:56AM  Blue Ridge Capital Reduces Position in Actavis
May-11-15 12:22PM  Talk Of A Stock Market Crash How Concerned Should We Be?
10:00AM  Late-Cycle Fervor Lifts Leveraged Materials ETF
09:05AM  Increased Medical Costs Affect Humanas EBITDA Margins in 1Q15
09:01AM  These Three Stocks Stressed Hedge Funds the Most Last Week
05:05AM  What Investors Can Expect from Pfizer in 2015
05:04AM  What Is the Risk-to-Reward on the PerrigoMylan Situation?
04:05AM  How the Mylan Bid Stacks Up to Similar Transactions
04:04AM  Whats the Spread in the PerrigoMylan transaction?
03:06AM  Humanas Commercial Enrollments Face Pressure in 1Q15
03:06AM  Humanas 1Q15 Medicare PDP and Medicaid Enrollments See Solid Growth
03:05AM  Teva Remains Committed to the Transaction with Mylan
May-10-15 10:01AM  How A $1.2 Billion Mutual Fund Manager Is Gearing Up For The Next Bear Market at Forbes
May-09-15 10:05PM  Pfizer Stock Dips over 1Q15 Forward Valuation Concerns
May-08-15 07:41PM  The Week Ahead: Are These Key Markets Changing Direction? at Forbes
01:02PM  A Quick Guide To Healthcare ETFs at Investopedia
12:06PM  Pfizer Revenues Hit by Lost Exclusivity in 1Q15
12:06PM  Pfizers Exposure to Overseas Markets Soaks 1Q15 Revenues
10:06AM  High Medical Costs Affect Centenes EBITDA Margins in 1Q15
01:06AM  Centenes 1Q15 Enrollments Increase in Key Sectors
01:06AM  Market Expansion Strategy Supports Centenes Growth in 1Q15
May-07-15 10:05PM  Universal Health Services Market Mix and Payer Mix Impact 1Q15
10:05PM  1Q15 Earnings Preview: HCA Holdings Stock Up 12.6%
05:47PM  Two Health Care ETFs With The Most Growth Potential: S&P Capital IQ at Forbes
01:44PM  Strong Medicare Advantage Enrollments Help Humana in 1Q15
01:42PM  Key Takeaways from Humanas 1Q15 Earnings Release
10:41AM  We're unique & biggest in healthcare: Athenahealth CEO
09:05AM  HCA Holdings: Will High-Income Markets Reduce Bad Debt in 1Q15?
09:05AM  HCA Holdings in 2015: Operating Expenses May Hit Margins
08:11AM  Sell The Inflation Trade?
May-06-15 11:07AM  Reduced Expenses Lead to Aetnas Higher 1Q15 Margins
09:06AM  Shares Rise 2% after Novartis Posts 1Q15 Earnings
08:37AM  GSK CEO: Our 3 key areas of strength
01:06AM  Aetnas Commercial Enrollments Increase 1Q15 Revenues
01:06AM  Pharmacy and Payment Strategy Add to Aetnas 1Q15 Growth
May-05-15 09:06PM  Why Novartiss Operating Margins Expanded in 1Q15
05:05PM  Admissions Expected to Drive HCA Holdings Revenues In 1Q15
04:06PM  Anthem Has Increased by ~13% Since 4Q14 Earnings Release
02:15PM  Predictions for first-quarter earnings arent panning out at MarketWatch
11:07AM  Universal Health Services Controls Operating and Capital Expenses
11:07AM  Universal Health Services Behavioral Health Segment Is Strong
11:06AM  Increased 1Q15 Costs to Hurt Anthems EBITDA Margins
11:06AM  Modest Commercial Enrollment Growth to Help Anthem in 1Q15
08:18AM  Tenet reports healthy Q1 results
07:04AM  Q1 earnings scorecard
May-04-15 10:06PM  Cignas Shares Up by 16.4% Since Its Previous Earnings Release
10:06PM  Cignas Increased Costs in 1Q15 Will Affect Its EBITDA Margins
02:06PM  Cigna Expects $1.8 Billion Spending for Capital Investments
02:06PM  Growing Medicare Advantage Expected to Boost Cignas 1Q15 Revenue
01:32PM  Strong Government-Sponsored Enrollments Help Centene in 1Q15 Market Realist
01:32PM  Key Takeaways from Centenes 1Q15 Earnings Release
12:44PM  This sector is a 'win-win' trade: Technician at CNBC
May-01-15 02:38PM  Top picks in health care
02:21PM  Sell in May and go away at your own peril at CNBC
10:45AM  Energy ETF Rally has Options Bears Waving the White Flag
Apr-30-15 10:05PM  Mylan Shareholders Well Placed in the MylanTeva Deal
11:25AM  Government-Sponsored Enrollments Boost Aetnas 1Q15 Revenues
11:24AM  Key Takeaways from Aetnas 1Q15 Earnings Release
09:36AM  Pisani's market open mixed
09:05AM  Strength of the US Dollar Takes a Toll on Novartis Revenues
Apr-29-15 01:29PM  Perrigo Rejects Mylans Increased Offer
01:18PM  Mylan Bumps Up Offer for Perrigo
01:03PM  The PerrigoMylan Proposal Faces some Big Hurdles
01:03PM  Mylan Launches Hostile Bid for Perrigo
12:17PM  United Health Services Acute Care Revenue Increases in 1Q15
12:17PM  Highlights from Universal Health Services 1Q15 Earnings Release
12:07PM  Mylan Versus Teva Pharmaceuticals: Takeover Defenses Are Weak
09:30AM  Small-Cap Sector ETFs to buy in May
05:06AM  How Much Can Teva Pharmaceuticals Afford to Pay for Mylan?
05:06AM  What Stage of the Business Cycle Are We In Now?
04:06AM  As US Economy Expands, Innovation Is Tide That Lifts All Boats
Apr-28-15 05:06PM  Humanas Shares Up by 18.8% since Its Previous Earnings
04:34PM  Pockets Of Value Persist In Sectors As Energy Makes Overall Market Look Fat at Forbes
03:17PM  Need new drug payment model: Aetna CEO
02:23PM  Government-Sponsored Enrollments to Drive Anthems 2015 Revenues
02:20PM  What to Expect from Anthems 1Q15 Earnings
01:39PM  Reason to be optimistic in biotech: Pro
01:20PM  Mylans Objections to Tevas Offer
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.